Navigation Links
Center Launches New International Stem Cell Research Institute

Cedars-Sinai Medical Center this week launched an International Stem Cell Research Institute that will conduct both adult and embryonic stem cell research. //

The academic medical center also announced the arrival of renowned Israeli developmental geneticist Nissim Benvenisty, M.D., Ph.D., as the institute’s co-director along with David I. Meyer, Ph.D., vice president of Research and Scientific Affairs at Cedars-Sinai.

“This is the time, this is the place, and Cedars-Sinai is ready to fulfill our vision for the promise of stem cell research,” said Benvenisty, speaking at the July 17 opening ceremony at Cedars-Sinai. Benvenisty was the first scientist in the world to grow human embryonic stem cells into embryoid bodies and the first to genetically manipulate them.

“Cedars-Sinai has a tradition of conducting research and clinical studies in a way where the emphasis stays on trying to quickly translate research findings from the bench to the bedside to benefit patients,” said Benvenisty. “The institute will perform research on all types of stem cells, emphasizing integrity, innovation and collaboration in our approach,” he added.

“It is hoped that this streamlined ‘bench to bedside’ approach to research will lead to more effective treatments in cardiovascular medicine, neuroscience, oncology, surgery and transplantation, among other areas,” said Meyer, who conceived the idea of the International Stem Cell Research Institute and actively recruited Benvenisty.

Benvenisty will maintain his current position as professor of genetics at Hebrew University in Jerusalem, where he and his family live. Later this summer, two more investigators will join the institute: Professor Michal Schwartz from the Weizmann Institute of Science in Israel and Professor Dan Gazit, also from Hebrew University.

Cedars-Sinai scientists have already been conducting more than a dozen research studies involving adult stem cells in
'"/>




Page: 1 2

Related medicine news :

1. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
2. Osaka Medical Center study showed 70% of smokers couldn’t qui
3. Kalam To Lay Foundation Of Vellore Research Center
4. Free Treatment Center Established In Chennai
5. Analyzing Client-Centered Therapy.
6. Human Milk Center Caters To Premature Babies
7. Walk-In Health Centers Launched By The NHS For Commuters
8. Free HIV Tests Brings Crowd to the Testing Centers
9. Kerala To Become Testing Center For US Bound Nurses
10. Himachal Pradesh Fails To Become Health Tourism Center
11. Vanderbilt-Ingram Cancer Center To Study Ways To Prevent Chemo Brain
Post Your Comments:
(Date:10/7/2008)... WASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -...ight for the second presidential debate, Jean,Berg...e Florida, will be in,the audience, waiting to ask...ts and make it harder for families to afford cover...y 28 years and has never had,healthcare., "It,s t...
(Date:10/7/2008)... Compression ultrasound similar to more expensive... , TUESDAY, Oct. 7 (HealthDay News) -- An o...leg -- called deep vein thrombosis, or DVT -- is a...esearch says. , European researchers found that...alled compression or duplex ultrasound -- was as g...
(Date:10/7/2008)... SEDONA, Ariz., Oct. 7 /PRNewswire/ -- Join M...or a four-day celebration in Sedona,s red rock,cou...Activities include a,series of traditional Native ... Program Director R.J. Joseph and special guest, E...espected Blackfoot Elder from the Blood Reserve,in...
(Date:10/7/2008)... MORE THAN 100,000 PEOPLE ACROSS THE NATION H... CURE(R), DALLAS, Oct. 7 /PRNewswire/ -- To...d all voters about the positions of presidential c... key health care and cancer issues,the Susan G. K...led a,series of resources available on its web sit...
Breaking Medicine News(10 mins):Health News:SEIU Member Will Be in Town Hall Audience, Ready to Ask John McCain Why He Won't Provide Affordable Healthcare for All 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3
...l toxins in corn may be the reason for neural tube...the early 1990's. The study published in the on ...gests that corn and its products //that have been ...ht give rise to neural tube defects (NTD), if cons...
...ng is reportedly being prohibited on the grounds o...on a vacation at Utah. The British Medical Journal...second hand smoke (SHS) does not raise the risk //... the measures as attempts by the powerful antismok...
...h officials in Argentina have reported an outbreak...der close to Paraguay. More than 70 cattle have be... province, //according to reports by National Serv... origin of the outbreak is yet to be identified an...
...an Letter, a male nurse aged 27, has admitted to k...hat nothing of what he says could actually justify...eat compassion to alleviate their pain.// He was ...urders to manslaughter, to reduce the penalty. The...
Other Medicine News:Health News:Fungal toxins infected corn the reason for congenital defects 2
(Date:10/7/2008)...of FLEXX Trial Presented at the Osteoarthritis Res... PARSIPPANY, N.J., Oct. 7 /- Ferring...rom the FLEXX Trial of Osteoarthritis of the,Knee,... a highly pure,non-avian high molecular weight for...uperior to intra-articular saline (IA-saline) for ...
(Date:10/7/2008)...nical study of adults, VYVANSE taken once-daily si...ne week, PHILADELPHIA, Oct. 7 /PRNewswire-FirstCa...obal specialty biopharmaceutical company, today,an...sue of the Journal of,Clinical Psychiatry found on...Deficit Hyperactivity Disorder (ADHD) symptoms in ...
(Date:10/7/2008)..., Calif., Oct. 7 /- Aerovance Inc. to...from a Phase I trial of its Aerovant,inhalation po...idence of,local irritancy following asthma patient... dose will be the highest of three doses investiga...hich is scheduled to begin early,next year. Eviden...
(Date:10/7/2008)...5 Patient Cohort Enrolled in Stage A of Trial Asse...h Carboplatin and Paclitaxel -, TUSTIN, Calif., O...uticals, Inc. (Nasdaq: PPHM ), a clinical stage b...ibodies for the treatment of cancer and,hepatitis ...as completed,enrollment in the first stage of a Ph...
Breaking Medicine Technology:Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Young Pop Stars Emphysema Startles Experts 22570 1Young Pop Stars Emphysema Startles Experts 22570 2Young Pop Stars Emphysema Startles Experts 22570 3Studies Show USGI Medicals EndoSurgical Operating System 28TM 29 Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass 6162 1Studies Show USGI Medicals EndoSurgical Operating System 28TM 29 Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass 6162 2Arterial Calcium Scans Can Predict Death Risk 22563 1Arterial Calcium Scans Can Predict Death Risk 22563 2Arterial Calcium Scans Can Predict Death Risk 22563 3Arterial Calcium Scans Can Predict Death Risk 22563 4Advertising Hall of Famer Charles D Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy 22559 1Advertising Hall of Famer Charles D Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy 22559 2
...ESS WIRE)--Jun 19, 2007 - Geron,Corporation (Nasda...the scalable production, survival following engraf...nfarcted rats was presented,today for GRNCM1, the ...herapeutic for heart failure, at the International...ting in Cairns,Australia., The presentation was o...
...ne 19, 2007 /PRNewswire-FirstCall/ --,Genaera Corp...ter,on trodusquemine (MSI-1436), its novel anti-ob...iation (ADA) 67th Scientific,Sessions, June 22 to ..., "Trodusquemine is a Multiple,Pathway Inhibitor t...sity, and Improves Plasma Insulin and Leptin Level...
Other Medicine Technology:Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 2Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 3Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 4Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 5Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 6Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant.
Intermittent catheter
Intermittent catheter
Medicine Products: